December 12, 2025 · Form 4 insider transaction
Nelson Jeffrey Edward bought 100,000 shares of Milestone Pharmaceuticals Inc., a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 47 days after the transaction.
Represents a performance stock unit ("PSU") award that vested upon the certification by the Compensation Committee of the Board of Directors of the Issuer that the U.S. Food and Drug Administration has provided a New Drug Application Approval Letter granting approval of Cardamyst (etripamil).; Each PSU represents a contingent right to receive one common share.